ERINA HERRON: Open Payments
NPI 1083223978 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 40 payments from 13 companies in 2025. Trend: 2023 $1,549 · 2024 $1,720 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $203 |
| Otsuka America Pharmaceutical, Inc. | 7 | $191 |
| AstraZeneca Pharmaceuticals LP | 2 | $146 |
| Bausch Health US, LLC | 4 | $95 |
| Lilly USA, LLC | 4 | $93 |
| PFIZER INC. | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Novo Nordisk Inc | 2 | $59 |
| ViiV Healthcare Company | 2 | $51 |
| ABBVIE INC. | 2 | $47 |
Products named: REXULTI, AIRSUPRA, Yeztugo, APLENZIN, MOUNJARO, NURTEC ODT, TRINTELLIX, Wegovy.
Industry payments across VA — which companies pay providers there.
